A detailed history of Marshall Wace, LLP transactions in Outset Medical, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 99,029 shares of OM stock, worth $78,232. This represents 0.0% of its overall portfolio holdings.

Number of Shares
99,029
Previous 314,187 68.48%
Holding current value
$78,232
Previous $1.21 Million 94.46%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.45 - $4.82 $96,821 - $1.04 Million
-215,158 Reduced 68.48%
99,029 $67,000
Q2 2024

Aug 14, 2024

BUY
$1.94 - $4.61 $505,835 - $1.2 Million
260,740 Added 487.85%
314,187 $1.21 Million
Q1 2024

May 15, 2024

BUY
$1.99 - $5.64 $66,091 - $187,315
33,212 Added 164.13%
53,447 $118,000
Q4 2023

Feb 14, 2024

BUY
$3.07 - $10.25 $62,121 - $207,408
20,235 New
20,235 $109,000
Q1 2023

May 15, 2023

BUY
$18.25 - $30.26 $2.21 Million - $3.67 Million
121,350 New
121,350 $2.23 Million
Q3 2022

Nov 14, 2022

BUY
$14.67 - $21.7 $249,566 - $369,160
17,012 Added 9.93%
188,276 $3 Million
Q2 2022

Aug 15, 2022

BUY
$13.46 - $48.16 $2.31 Million - $8.25 Million
171,264 New
171,264 $2.55 Million
Q1 2022

May 16, 2022

SELL
$34.22 - $47.24 $1.98 Million - $2.73 Million
-57,869 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$43.29 - $58.77 $594,414 - $806,970
13,731 Added 31.11%
57,869 $2.67 Million
Q3 2021

Nov 15, 2021

BUY
$36.86 - $54.98 $1.63 Million - $2.43 Million
44,138 New
44,138 $2.18 Million
Q2 2021

Aug 13, 2021

SELL
$41.49 - $59.92 $5.42 Million - $7.83 Million
-130,734 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$46.94 - $58.66 $5.39 Million - $6.74 Million
-114,867 Reduced 46.77%
130,734 $7.11 Million
Q4 2020

Feb 16, 2021

BUY
$42.51 - $64.0 $10.4 Million - $15.7 Million
245,601 New
245,601 $14 Million

Others Institutions Holding OM

About Outset Medical, Inc.


  • Ticker OM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 48,007,300
  • Market Cap $37.9M
  • Description
  • Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...
More about OM
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.